Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Evaluation of EV1000™/volumeView™ for Cardiac Output Monitoring in Liver Transplantation
Completed
- Conditions
- Liver Disease
- Interventions
- Device: EV1000™/volumeView™
- First Posted Date
- 2014-12-03
- Last Posted Date
- 2016-05-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT02306018
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Screening Protocol for The VIKTORY Trial
Not Applicable
Completed
- Conditions
- Stomach Neoplasms
- Interventions
- Other: Molecular profiling
- First Posted Date
- 2014-11-24
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 651
- Registration Number
- NCT02299648
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical center, Seoul, Korea, Republic of
Personalized Sequence for Thoracic, Esophageal, and H&N Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2014-11-24
- Last Posted Date
- 2021-03-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT02299622
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome
Not Applicable
Completed
- Conditions
- Myofascial Pain Syndrome
- Interventions
- Drug: trigger point injection
- First Posted Date
- 2014-11-18
- Last Posted Date
- 2014-11-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 61
- Registration Number
- NCT02293083
Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial
Not Applicable
Terminated
- Conditions
- Locally Advanced Rectal Cancer
- Interventions
- Radiation: Hyperthermia with concurrent chemo-radiation therapy
- First Posted Date
- 2014-11-14
- Last Posted Date
- 2019-11-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT02290574
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)
Phase 2
- Conditions
- Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
- Interventions
- Radiation: Scheduled interval TACE - RT
- First Posted Date
- 2014-11-14
- Last Posted Date
- 2014-12-05
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02290977
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas
- First Posted Date
- 2014-11-02
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT02280785
- Locations
- 🇰🇷
Korean Cancer Center Hospital, Seoul, Korea, Republic of
🇰🇷National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷Yonsei Severance Hospital, Seoul, Korea, Republic of
Evaluation of SVV From NICOM as a Predictor of Fluid Responsiveness in Prone Position During Spine Surgery
Completed
- Conditions
- Fluid ResponsivenessNon Invasive Cardiac Output MonitoringProne Position
- Interventions
- Other: Fluid loading to evaluate fluid responsiveness
- First Posted Date
- 2014-10-29
- Last Posted Date
- 2015-07-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02277353
- Locations
- 🇰🇷
Samsung Seoul Hospital, Samsung Medical Center, Seoul, Korea, Republic of
Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage
- First Posted Date
- 2014-10-24
- Last Posted Date
- 2017-04-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 9
- Registration Number
- NCT02274428
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction
Not Applicable
- Conditions
- Biliary Tract Neoplasms
- Interventions
- Device: partially covered SEMSDevice: fully covered SEMS
- First Posted Date
- 2014-10-02
- Last Posted Date
- 2015-02-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 106
- Registration Number
- NCT02255669
- Locations
- 🇰🇷
Samsung Medical Cencer, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath